17
scientific programme
Friday, 17 October 2014
oo1
Social exclusion leads to a reduction of oxytocin plasma
levels in borderline patients and patients with chronic
depression compared to healthy subjects
Andrea Jobst, Munich, Germany
Lena Sabass, Babette Renneberg, Anna Albert, Peter Zill,
Anna Buchheim, Frank Padberg
oo2
Effects of serotonin depletion on punishment processing
in the orbito frontal and anterior cingulate cortices in
healthy women
Katrin Helmbold, Aachen, Germany
Mikhail Zvyagintsev, Brigitte Dahmen, Sarah Bubenzer-
Busch, Tilman J. Gaber, Molly Crockett, Martin Klasen,
Cristina Lucia Sanchez, Albrecht Eisert, Kerstin Konrad,
Ute Habel, Beate Herpertz-Dahlmann, Florian Zepf
oo3
A double-blind, placebo-controlled trial of quetiapine xr
in borderline personality disorder
S. Charles Schulz, Minneapolis, USA
Donald Black, Mary Zanarini, Ann Romine, Martha Shaw,
Jeff Allen
S-18
Symposium
09:00–10:30
Auditorium Medici /Visconti
Borderline personality disorder, substance abuse and
mentalization-based treatment (MBT)
Chairpersons: Sigmund Karterud, Oslo, Norway
Nina Arefjord, Bergen, Norway
oo1
BPD, SUD and MBT. An introduction
Sigmund Karterud, Oslo, Norway
oo2
A mentalization-based treatment (MBT) pilot trial for
female borderline patients with addiction
Nina Arefjord, Bergen, Norway
oo3
Stimulating mentalization as a change mechanism in
psychotherapy for borderline personality disorder and
substance use disorders
Björn Philips, Stockholm, Sweden
Clara Möller, Fredrik Falkenström, Linda Karlgren, Anton
Sandell
oo4
Mentalizing the transference in the treatment of perso-
nality disorders and addiction
Katharina Teresa Morken, Bergen, Norway
S-19
Symposium
09:00–10:30
Room Tivoli
Mentalization-based treatment in forensic settings
Chairpersons: Jessica Yakeley, London, United Kingdom
Gwen Adshead, London, United Kingdom
oo1
Treating the untreatable? Mentalization-based treatment
for antisocial personality disorder in the community
Jessica Yakeley, London, United Kingdom
oo2
Mentalization-based treatment for the highly disorganised
mind
Gwen Adshead, London, United Kingdom
Claire Wilson
oo3
MBT for men with complex co-morbid psychopathology
Martin Humphrey, London, United Kingdom
Claire Wilson
S-20
Symposium
09:00–10:30
Room Estensi
Refining treatments for borderline personality disorder
in young people – Part 2
Chairpersons: Andrew Chanen, Melbourne, Australia
Louise McCutcheon, Melbourne, Australia
oo1
Changes in personality functioning in adolescents during
treatment
Joost Hutsebaut, Halsteren, The Netherlands
Dineke Feenstra
oo2
Is detection and treatment of adolescent self-harm a
suitable strategy for the treatment of borderline person
ality disorder?
Michael Kaess, Heidelberg, Germany
Gloria Fischer, Peter Parzer, Franz Resch, Romuald
Brunner
oo3
What elements are necessary for effective treatment of
borderline personality disorder in youth?
Louise McCutcheon, Melbourne, Australia
Andrew Chanen
